Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:862-866
Published online before print August 9, 2004, doi: 10.1161/01.CIR.0000138746.14425.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/7/862    most recent
01.CIR.0000138746.14425.00v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norman, P.
Right arrow Articles by Jamrozik, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norman, P.
Right arrow Articles by Jamrozik, K.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Other diagnostic testing
Right arrow CV surgery: aortic and vascular disease

(Circulation. 2004;110:862-866.)
© 2004 American Heart Association, Inc.


Original Articles

C-Reactive Protein Levels and the Expansion of Screen-Detected Abdominal Aortic Aneurysms in Men

Paul Norman, MB, ChB, DS, FRACS; Carole A. Spencer; Michael M. Lawrence-Brown, MB, BS, FRACS; Konrad Jamrozik, MBBS, DPhil, FAFPH

From the School of Surgery and Pathology, The University of Western Australia, Fremantle Hospital, Fremantle, Western Australia (P.N.); the School of Population Health, The University of Western Australia, Perth, Western Australia (C.A.S., K.J.); The Mount Hospital, Perth, Western Australia (M.M.L.-B.); and the Department of Primary Health Care and General Practice, and Imperial College London (K.J.).

Correspondence to Prof Paul Norman, School of Surgery and Pathology, Fremantle Hospital, PO Box 480, Fremantle, Western Australia 6959. E-mail pnorman{at}cyllene.uwa.edu.au

Received September 2, 2003; de novo received February 6, 2003; accepted April 13, 2004.

Background— C-reactive protein (CRP) levels have been shown to predict a number of cardiovascular outcomes. CRP levels have also been found to be elevated in patients with abdominal aortic aneurysms (AAAs). The aim of this study was to assess the relation between CRP levels and rates of expansion of small AAAs.

Methods and Results— A cohort of men with small aneurysms was identified in a trial of screening with ultrasound scanning. After initial screening, men were rescanned at 6- to 12-month intervals. CRP levels were measured at the first follow-up visit. Rates of expansion and risk factors for expansion were assessed with the use of data from 545 men who attended for at least 1 scan after CRP levels were measured. These men were followed for a median of 48 (range, 5 to 69) months. The mean annual rate of expansion was 1.6 mm. The median CRP level was 2.6 mg/L in men with the smaller AAAs (30 to 39 mm, n=433) compared with 3.5 mg/L in men with larger AAAs (40 to 54 mm, n=112) (P=0.007). The multivariate age-adjusted logistic model confirmed initial aortic diameter to be the only factor associated with rapid expansion with an odds ratio of 7.2 (95% CI, 4.3,12.2) for an initial diameter of 40 to 54 mm relative to one of 30 to 39 mm.

Conclusions— Most small aneurysms expand slowly. CRP levels are elevated in larger aneurysms but do not appear to be associated with rapid expansion. The most useful predictor of aneurysmal expansion in men is aortic diameter.


Key Words: aorta • aneurysm • proteins • risk factors




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
P. E Norman, L. Flicker, O. P Almeida, G. J Hankey, Z. Hyde, and K. Jamrozik
Cohort Profile: The Health In Men Study (HIMS)
Int. J. Epidemiol., March 3, 2008; (2008) dyn041v1.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Golledge, M. Karan, C. S. Moran, J. Muller, P. Clancy, A. E. Dear, and P. E. Norman
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions
Eur. Heart J., March 1, 2008; 29(5): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman
Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study
Circulation, November 13, 2007; 116(20): 2275 - 2279.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Inoue, A. Sugiyama, P. C. Reid, Y. Ito, K. Miyauchi, S. Mukai, M. Sagara, K. Miyamoto, H. Satoh, I. Kohno, et al.
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Golledge, J. Muller, A. Daugherty, and P. Norman
Abdominal Aortic Aneurysm: Pathogenesis and Implications for Management
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2605 - 2613.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Shiraya, K. Miwa, M. Aoki, T. Miyake, M. Oishi, K. Kataoka, S. Ohgi, T. Ogihara, Y. Kaneda, and R. Morishita
Hypertension Accelerated Experimental Abdominal Aortic Aneurysm Through Upregulation of Nuclear Factor {kappa}B and Ets
Hypertension, October 1, 2006; 48(4): 628 - 636.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. S. Moran, M. McCann, M. Karan, P. Norman, N. Ketheesan, and J. Golledge
Association of Osteoprotegerin With Human Abdominal Aortic Aneurysm Progression
Circulation, June 14, 2005; 111(23): 3119 - 3125.
[Abstract] [Full Text] [PDF]